4.8 Article

Phosphorylation of EXO1 by CDKs 1 and 2 regulates DNA end resection and repair pathway choice

期刊

NATURE COMMUNICATIONS
卷 5, 期 -, 页码 -

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/ncomms4561

关键词

-

资金

  1. National Institutes of Health [RO1 CA149461]
  2. National Aeronautics and Space Administration [NNX13AI13G]
  3. Cancer Prevention and Research Institute of Texas [RP100644]
  4. National Health and Medical Research Council
  5. Foundation ARC
  6. National Institute of General Medical Sciences training in cellular and molecular biology [5T32GM008203]
  7. Division Of Integrative Organismal Systems
  8. Direct For Biological Sciences [0923752] Funding Source: National Science Foundation

向作者/读者索取更多资源

Resection of DNA double-strand breaks (DSBs) is a pivotal step during which the choice between NHEJ and HR DNA repair pathways is made. Although CDKs are known to control initiation of resection, their role in regulating long-range resection remains elusive. Here we show that CDKs 1/2 phosphorylate the long-range resection nuclease EXO1 at four C-terminal S/TP sites during S/G2 phases of the cell cycle. Impairment of EXO1 phosphorylation attenuates resection, chromosomal integrity, cell survival and HR, but augments NHEJ upon DNA damage. In contrast, cells expressing phospho-mimic EXO1 are proficient in resection even after CDK inhibition and favour HR over NHEJ. Mutation of cyclin-binding sites on EXO1 attenuates CDK binding and EXO1 phosphorylation, causing a resection defect that can be rescued by phospho-mimic mutations. Mechanistically, phosphorylation of EXO1 augments its recruitment to DNA breaks possibly via interactions with BRCA1. In summary, phosphorylation of EXO1 by CDKs is a novel mechanism regulating repair pathway choice.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据